| Literature DB >> 17894886 |
Roger A Barthelson1, Georgina M Lambert, Cheryl Vanier, Ronald M Lynch, David W Galbraith.
Abstract
BACKGROUND: In the most general sense, studies involving global analysis of gene expression aim to provide a comprehensive catalog of the components involved in the production of recognizable cellular phenotypes. These studies are often limited by the available technologies. One technology, based on microarrays, categorizes gene expression in terms of the abundance of RNA transcripts, and typically employs RNA prepared from whole cells, where cytoplasmic RNA predominates.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17894886 PMCID: PMC2048942 DOI: 10.1186/1471-2164-8-340
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Human genomic microarrays: a comparison of intensity values for nuclear, cytoplasmic, and total RNA samples. The median intensity values from the hybridization of amplified RNA samples to the 70-mer probes on the human genomic microarrays were log-transformed and normalized. The least-squares mean log values from the mixed model ANOVA were plotted against each other to view the relative intensities for the following samples: Blue, nuclear (ordinate) versus cytoplasmic (abscissa) RNA; Green, nuclear (ordinate) versus total (abscissa) RNA; and Red, total (ordinate) versus cytoplasmic (abscissa) RNA. A least squares regression line was fitted to each set of points to visually demonstrate the linear relationship; the associated correlation coefficients are presented in colors that match the lines and the data points.
Figure 2MicroRNA microarrays: a comparison of intensity values for nuclear, cytoplasmic, and total RNA samples. Sense DNA (reverse-transcribed, amplified RNA) samples were hybridized to the oligo probes (doublets of 18–22 nucleotides) on the MirMax miRNA microarrays. Hybridization of these samples to the miRNA arrays indicates the concentration of pri-miRNA in the RNA samples. The resulting intensity values were analyzed as given in Figure 1, and plotted with the same color key. A least squares regression line was fitted to each set of points to visually demonstrate the linear relationship; the associated correlation coefficients are presented in colors that match the lines and the data points.
Figure 3GO cell component analysis of nucleus-enriched and cytoplasm-enriched transcripts. The lists of nucleus-enriched (relative to cytoplasm) and cytoplasm-enriched (relative to nucleus) transcripts were calculated for the human genomic microarray data by ANOVA and by selection of those with a FDR less than 0.05. These two lists were submitted independently for analysis by GOToolbox [27] to determine the cell component annotation of the transcripts, and to determine whether some of the annotation categories were overrepresented on the lists, using the hypergeometric test with Benjamini and Hochberg FDR calculation. Some of the categories with strong representation among the transcripts are presented here. The transcripts that were placed in each category are identified by gene name or abbreviated TREMBL identifier and color-coded to indicate the ratio of the log, mean, normalized intensity values of the nuclear sample over the cytoplasmic sample. Where the lists for nuclear or cytoplasmic transcripts show overrepresentation in a GO category, the FDR is provided.
Figure 4GO biological process analysis of nucleus-enriched and cytoplasm-enriched transcripts. Details are the same as for Figure 3, except the lists of transcripts were annotated using the biological process categories.
Figure 5Cluster analysis of the miRNA primary transcripts identified in the nuclear, total, and cytoplasmic fractions of the HepG2 cells. Analysis is based solely on the log ratios of the mean normalized intensity values from the hybridization of the reverse-transcribed amplified RNA samples to the miRNA microarrays. The Cluster and Treeview programs that are found on the GEPAS website [69] were used to compare 1)nuclear to cytoplasmic, 2)nuclear to total, and 3)cytoplasmic to total ratios, which are color-coded to represent the log ratios of the mean intensity values as indicated. The clustering was performed with complete linkage using the euclidean distance, and the unweighted pair group method with arithmetic averages.
Figure 6The lists of nucleus-enriched and cytoplasm-enriched transcripts were analyzed for potential interactions by the proteins represented by the transcripts. The analysis was performed with Osprey software, which employs The Biogrid [49], a database of protein-protein interactions based on in vitro, in vivo, yeast two-hybrid system, and affinity-capture mass spectrometry experimentation. The main grouping of interacting proteins that resulted is presented here. Those proteins that represented nucleus-enriched transcripts are marked with an 'N'. The proteins are labeled with the corresponding gene name, and the annotation information for the proteins is provided in Table 1. Each protein is color coded according to its annotation heading. The experimental system(s) employed to determine the protein-protein relationship is indicated by the color coding of the arrows.
Proteins in the Interaction Network
| Name | Description | Go Component | Go Process |
| aryl hydrocarbon receptor | nucleus | cell cycle;response to stress;apoptosis | |
| AHA1, activator of heat shock 90 kDa ATPase homolog 1 (yeast) | ER;cytoplasm | response to stress;protein folding | |
| APEX nuclease (multifunctional DNA repair enzyme) 1 | nucleus;ER;ribosom | base-excision repair;DNA repair | |
| cyclin T1 | nucleus | cytokinesis;regulation of cell cycle | |
| X-ray repair in Chinese hamster cells 6 | nucleus | double-strand break;DNA repair | |
| homeodomain interacting protein kinase 2 | nucleus;nuclear body;cytoplasm | apoptosis;reg. of cell cycle | |
| heat shock 90 kDa protein 1, alpha | cytosol | mitochondrial transport;protein refolding | |
| microphthalmia-associated transcription factor | nucleus | regulation of transcription; melanocyte differentiation | |
| NudC domain containing 3 | NONE | NONE | |
| protein inhibitor of activated STAT, 1 | nucleus | ubiquitin cycle;regulation of transcription | |
| phosphatase and tensin homolog (mutated in cancers 1) | cytoplasm | negative reg. of cell cycle;induction of apoptosis | |
| SET translocation (myeloid leukemia-associated) | ER;perinuclear region;nucleus | nucleocytoplasm transport;DNA replic.;nucleosome assembly | |
| SMT3 suppressor of mif two 3 homolog 1 (yeast) | nucleus | ubiquitin cycle;protein modification;protein sumoylation | |
| SMT3 suppressor of mif two 3 homolog 2 (yeast) | nucleus | ubiquitin cycle;protein modification | |
| SMT3 suppressor of mif two 3 homolog 3 (yeast) | kinetochore | ubiquitin cycle;protein modification | |
| telomerase reverse transcriptase | chromosome, telomeric region;nucleus | RNA-dependent DNA replication;telomere maintenance | |
| TNFRSF1A-associated via death domain | NONE | induction of apoptosis | |
| thioredoxin | NONE | electron transport;cell-cell signaling;cell motility;cell prolif. | |
| ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | NONE | ubiquitin cycle;protein modification | |
| X-ray repair in Chinese hamster cells 1 | intracellular;nucleus | single strand break repair |